Company intelligence / Profile preview

Farmaprim

Ownership: Private
Employees: ~170
Development stage: Other

Overview

Farmaprim is Moldova’s only manufacturer specializing in semi-solid pharmaceutical dosage forms such as suppositories, pessaries, ointments, gels, and creams. With over 100 products marketed across CIS countries, parts of the EU, Africa, and Asia since its founding in 1999, the company operates a modern GMP-compliant facility with ISO certifications. Its portfolio covers multiple therapeutic areas with an emphasis on high-quality generics for export markets[1][4][5].

Modalities: Small moleculeCreamGelOintmentSuppositoryPessary
Industry: Biotech

Drug pipeline

1 asset

Aneczem

Unknown

Beyond the preview

Go deeper on Farmaprim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farmaprim.

Explore the full profile